Jason R Gee

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. doi request reprint Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin
    Jason R Gee
    Department of Urology, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI 53792, USA
    BJU Int 103:736-9. 2009
  2. pmc Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer
    Jason R Gee
    Department of Urology, William S Middleton Memorial Veterans Hospital, and Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Anticancer Res 29:3769-75. 2009
  3. pmc Flexible and rigid cystoscopy in women
    Jason R Gee
    Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
    JSLS 13:135-8. 2009
  4. ncbi request reprint Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques
    Gyan Pareek
    Division of Urology, Department of Surgery, University of Wisconsin Medical School, Madison, Wisconsin, USA
    J Urol 175:1208-13. 2006
  5. pmc A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients
    Edward Messing
    University of Rochester Medical Center, Rochester, New York, USA
    Cancer Prev Res (Phila) 5:621-30. 2012
  6. pmc A Bayesian adaptive design with biomarkers for targeted therapies
    Jens C Eickhoff
    Department of Biostatistics and Medical Informatics, University of Wisconsin Madison, Madison, WI, USA
    Clin Trials 7:546-56. 2010

Detail Information

Publications6

  1. doi request reprint Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin
    Jason R Gee
    Department of Urology, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI 53792, USA
    BJU Int 103:736-9. 2009
    ....
  2. pmc Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer
    Jason R Gee
    Department of Urology, William S Middleton Memorial Veterans Hospital, and Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Anticancer Res 29:3769-75. 2009
    ..Here we investigate molecular effects of celecoxib independent of cyclooxygenase (COX)-2 expression levels in urothelial carcinoma of the bladder...
  3. pmc Flexible and rigid cystoscopy in women
    Jason R Gee
    Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
    JSLS 13:135-8. 2009
    ..Similar studies, however, have not been performed in women. We sought to determine whether office-based flexible cystoscopy was better tolerated than rigid cystoscopy in women...
  4. ncbi request reprint Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques
    Gyan Pareek
    Division of Urology, Department of Surgery, University of Wisconsin Medical School, Madison, Wisconsin, USA
    J Urol 175:1208-13. 2006
    ..We performed a meta-analysis of the literature to define the current expectations of complications during laparoscopic renal surgery...
  5. pmc A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients
    Edward Messing
    University of Rochester Medical Center, Rochester, New York, USA
    Cancer Prev Res (Phila) 5:621-30. 2012
    ..Genistein displayed a possible bimodal effect (more effective at the lower dose) on bladder cancer tissue EGFR phosphorylation that should be evaluated further, possibly in combination with other agents...
  6. pmc A Bayesian adaptive design with biomarkers for targeted therapies
    Jens C Eickhoff
    Department of Biostatistics and Medical Informatics, University of Wisconsin Madison, Madison, WI, USA
    Clin Trials 7:546-56. 2010
    ..In traditional clinical trials, treatment effects for various biomarkers are typically evaluated in an exploratory fashion and only limited information about the predictive values of biomarkers obtained...